glp 1 drugs and rheumatoid arthritis Glucagon-like peptide its receptor agonists for the treatment of rheumatic diseases Targeting the GLP-1/GLP-1R axis to

: 1- 30 2- 2 6 3- 4 4- 5- 3 6- : 2 7- 7 8- 9- 8 10- 11- 12- () 13- 14- 15- 16- 17- 18- ( ) 19- 20- C B 21- 22- 23- 24- 25- 26- 27- 28- 2- 2 6 3- 4 4- 5- 3 6- : 2 7- 7 8- 9- 8 10- 11- 12- () 13- 14- 15- 16- 17- 18- ( ) 19- 20- C B 21- 22- 23- 24- 25- 26- 27- 28- : 1-

Cortistatin promotes this synchronization directly Homeostatic regulation -- preprocortistatin mRNA is upregulated after sleep deprivation and follows a circadian rhythm, indicating that cortistatin functions as an endogenous homeostatic sleep factor BDNF-dependent expression -- brain-derived neurotrophic factor regulates cortistatin expression in an activity-dependent manner, linking neuronal activity during wakefulness to subsequent sleep drive Cortistatin's receptor pharmacology is well-defined

Burns also noted that in 2024, Wegovy, Zepbound, and Ozempic had nearly half a billion dollars in advertising behind them, and asked a fair question: if these drugs work so well, why the need to market them so aggressively

Corpeleijn WE, Kouwenhoven SM, Paap MC, van Vliet I, Scheerder I, Muizer Y, et al